<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">HJBM</journal-id><journal-title-group><journal-title>Hans Journal of Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2161-8976</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/HJBM.2021.111002</article-id><article-id pub-id-type="publisher-id">HJBM-39866</article-id><article-categories><subj-group subj-group-type="heading"><subject>HJBM20210100000_33029252.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  YAP/TAZ蛋白调控病毒侵染与免疫的研究进展
  Research Progress of YAP/TAZ Protein Regulating Virus Infection and Immunity
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>邹</surname><given-names>丰</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>苟</surname><given-names>洪伟</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>黄</surname><given-names>金华</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>李</surname><given-names>晨辉</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>赵</surname><given-names>铁军</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>浙江师范大学化学与生命科学学院，浙江 金华</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>20</day><month>01</month><year>2021</year></pub-date><volume>11</volume><issue>01</issue><fpage>8</fpage><lpage>13</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  YAP/TAZ介导的Hippo信号通路在生命进程中扮演重要角色，它主要调控器官大小，胚胎发育，细胞增殖以及肿瘤发生等。最新研究发现Hippo信号通路关键蛋白YAP/TAZ在调控人类病毒侵染及免疫反应中发挥非常重要的作用。文章总结了YAP/TAZ蛋白的病理学特征，重点介绍YAP/TAZ蛋白在调控人类病毒侵染、复制、诱发疾病以及免疫调控中的功能及其机理，以期为病毒致病机制研究及治疗手段开发提供新的见解和思路。
   Accumulating evidence showed that YAP/TAZ mediated Hippo pathway plays a critical role in bio-logical processes, including the control of organ size, embryonic development, cell proliferation, and cancer development. The Hippo signaling pathway key protein YAP/TAZ has been found to play a very important role in human virus infection and immunity. This paper summarizes the pathologic characteristics of YAP/TAZ protein, and focuses on the functions and mechanisms of YAP/TAZ pro-tein in the regulation of human virus infection, replication, disease induction and immune regula-tion. It might give new insights into the research of viral disease and its therapy.
 
</p></abstract><kwd-group><kwd>YAP/TAZ蛋白，Hippo信号通路，病毒侵染，免疫，发病机理, YAP/TAZ</kwd><kwd> Hippo Signaling Pathway</kwd><kwd> Virus Infection</kwd><kwd> Immunity</kwd><kwd> Pathogenesis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>YAP/TAZ介导的Hippo信号通路在生命进程中扮演重要角色，它主要调控器官大小，胚胎发育，细胞增殖以及肿瘤发生等。最新研究发现Hippo信号通路关键蛋白YAP/TAZ在调控人类病毒侵染及免疫反应中发挥非常重要的作用。文章总结了YAP/TAZ蛋白的病理学特征，重点介绍YAP/TAZ蛋白在调控人类病毒侵染、复制、诱发疾病以及免疫调控中的功能及其机理，以期为病毒致病机制研究及治疗手段开发提供新的见解和思路。</p></sec><sec id="s2"><title>关键词</title><p>YAP/TAZ蛋白，Hippo信号通路，病毒侵染，免疫，发病机理</p></sec><sec id="s3"><title>Research Progress of YAP/TAZ Protein Regulating Virus Infection and Immunity</title><p>Feng Zou, Hongwei Gou, Jinhua Huang, Chenhui Li, Tiejun Zhao<sup>*</sup></p><p>College of Chemistry and Life Sciences, Zhejiang Normal University, Jinhua Zhejiang</p><p><img src="//html.hanspub.org/file/2-1530157x4_hanspub.png" /></p><p>Received: Dec. 25<sup>th</sup>, 2020; accepted: Jan. 8<sup>th</sup>, 2021; published: Jan. 20<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/2-1530157x5_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Accumulating evidence showed that YAP/TAZ mediated Hippo pathway plays a critical role in biological processes, including the control of organ size, embryonic development, cell proliferation, and cancer development. The Hippo signaling pathway key protein YAP/TAZ has been found to play a very important role in human virus infection and immunity. This paper summarizes the pathologic characteristics of YAP/TAZ protein, and focuses on the functions and mechanisms of YAP/TAZ protein in the regulation of human virus infection, replication, disease induction and immune regulation. It might give new insights into the research of viral disease and its therapy.</p><p>Keywords:YAP/TAZ, Hippo Signaling Pathway, Virus Infection, Immunity, Pathogenesis</p><disp-formula id="hanspub.39866-formula12"><graphic xlink:href="//html.hanspub.org/file/2-1530157x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/2-1530157x8_hanspub.png" /> <img src="//html.hanspub.org/file/2-1530157x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>大量研究表明Hippo通路参与调控细胞增殖，器官大小 [<xref ref-type="bibr" rid="hanspub.39866-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref2">2</xref>]。近年来，Hippo信号通路在疾病调控中发挥着越来越重要的作用，尤其是YAP/TAZ蛋白对病毒侵染及免疫反应的调控受到广泛关注。研究报道Hippo/YAP通路在调节一种表达CXCR2的髓源性抑制细胞(MDSCs)的C-X-C基序趋化因子配体5 (CXCL5)时具有非自主功能。当癌细胞中YAP过度活化时，CXCL5分泌增强，进而募集更多MDSCs，促进肿瘤发生。在胰腺导管腺癌中，YAP促进MDSCs分化积累，调节免疫抑制；而当YAP或MDSCs缺失时，免疫反应增强 [<xref ref-type="bibr" rid="hanspub.39866-ref3">3</xref>]。另有研究表明，YAP能够引导肿瘤相关巨噬细胞TAMs向免疫抑制/亲肿瘤M2表型分化。在小鼠肝脏肿瘤模型中，单个肿瘤起始细胞可通过YAP诱导CCL2和CSF1表达，促进髓源性抑制细胞和M2巨噬细胞的招募，进而促进肿瘤发生 [<xref ref-type="bibr" rid="hanspub.39866-ref4">4</xref>]。文章总结了YAP/TAZ蛋白对病毒侵染的调控机制，同时综述了YAP/TAZ与免疫调控的研究进展。</p></sec><sec id="s6"><title>2. Hippo通路及YAP/TAZ蛋白</title><p>Hippo通路是一条首先在果蝇中被发现的信号通路。Hippo通路在哺乳动物中同样高度保守，调节细胞接触抑制及肿瘤发生 [<xref ref-type="bibr" rid="hanspub.39866-ref5">5</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref6">6</xref>]。在哺乳动物细胞中，Hippo通路由TAOK1-3激酶磷酸化，进而激活MST1/2起始 [<xref ref-type="bibr" rid="hanspub.39866-ref7">7</xref>]。随后，MST1/2通过与调节蛋白SAV1互作从而激活LATS1/2激酶活性 [<xref ref-type="bibr" rid="hanspub.39866-ref8">8</xref>]。此外，MST1/2还可促进MOB1与LATS1/2互作，而MOB1的磷酸化可导致LATS1/2被完全激活 [<xref ref-type="bibr" rid="hanspub.39866-ref9">9</xref>]。研究发现，神经纤维肿瘤抑制因子NF2通过MST1/2-SAV1复合物促进LATS1/2磷酸化 [<xref ref-type="bibr" rid="hanspub.39866-ref10">10</xref>]。同样MAP4K家族、环腺苷酸(cAMP)也能激活LATS1/2活性，而LPA和S1P会抑制LATS1/2活性 [<xref ref-type="bibr" rid="hanspub.39866-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref13">13</xref>]。LATS1/2激活可以直接磷酸化YAP和TAZ，使其滞留在胞浆中，从而抑制下游靶基因表达。LATS1/2激酶可以磷酸化YAP五个关键位点(TAZ四个)，其中，YAP<sup>Ser127/381</sup>位，TAZ<sup>Ser89/311</sup>位与蛋白入核及蛋白降解密切相关 [<xref ref-type="bibr" rid="hanspub.39866-ref1">1</xref>]。YAP<sup>Ser127</sup>/TAZ<sup>S89</sup>位磷酸化后与14-3-3蛋白结合，使YAP蛋白定位在细胞质中。而YAP<sup>S381/</sup>TAZ<sup>S311</sup>位磷酸化引起酪蛋白激酶1(CK1δ/ε)诱导的进一步磷酸化，从而使YAP/TAZ招募SCFβ-TRCP E3连接酶，从而走向泛素化及蛋白酶体依赖的降解途径 [<xref ref-type="bibr" rid="hanspub.39866-ref14">14</xref>]。相反，当激酶模块失活时，低磷酸化的YAP/TAZ可以穿梭到细胞核，并通过与转录因子TEAD相互作用而充当转录共激活因子。TEAD是哺乳动物Hippo信号通路中关键的转录激活因子，而YAP被认为是TEAD的转录共激活因子，二者在细胞核内互作，诱导与细胞增殖，分化，发育和凋亡相关的下游靶基因表达，如结缔组织生长因子(CTGF)、富半胱氨酸诱导因子61(CYR61)、神经肽-1(NRP1)等 [<xref ref-type="bibr" rid="hanspub.39866-ref15">15</xref>]，最终影响细胞生长，增殖及迁移(见图1)。</p><p>图1. Hippo信号通路及其关键蛋白YAP/TAZ</p></sec><sec id="s7"><title>3. YAP/TAZ病理学功能</title><p>YAP/TAZ蛋白异常调控会影响细胞增殖，凋亡，迁移和分化，从而导致包括癌症在内的多种疾病产生。在肝癌，食道癌，胃癌，前列腺癌，结肠癌，肺癌，乳腺癌等人类癌症中，检测到癌细胞中YAP/TAZ过表达及其在细胞核内定位 [<xref ref-type="bibr" rid="hanspub.39866-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref18">18</xref>]。在肝癌，结肠癌，食道癌，卵巢癌病人中，YAP/TAZ过表达与患者不良预后密切相关 [<xref ref-type="bibr" rid="hanspub.39866-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref20">20</xref>]。在癌症发生过程中，Hippo信号通路异常调控主要是通过影响上游激酶LATS1/2和MST1/2的活性，从而导致YAP/TAZ低磷酸化及其富集于核内 [<xref ref-type="bibr" rid="hanspub.39866-ref16">16</xref>]。</p><p>在哺乳动物中，YAP/TAZ蛋白也调控一些非肿瘤型疾病。例如，在一个长期神经受损的动物模型中，研究发现YAP/TAZ主要聚集在核内，由此导致外周神经损伤水平上升。研究发现在特异性缺失YAP/TAZ的小鼠心脏模型中，小鼠会表现出心脏发育缺陷的生理现象。此外，YAP过表达会激活心肌细胞增殖，而成年小鼠心脏中缺失SAV则会增强YAP表达，从而激活心肌细胞增殖 [<xref ref-type="bibr" rid="hanspub.39866-ref21">21</xref>]。</p><p>越来越多研究表明，Hippo通路YAP/TAZ蛋白在调控人类病毒侵染诱导的肿瘤疾病、调控免疫反应等方面发挥关键作用。</p></sec><sec id="s8"><title>4. YAP/TAZ蛋白对病毒侵染的调控作用</title><p>常见的人类病毒，例如HBV、HPV、KSHV、EBV、ZIKV等，均能通过调控Hippo信号通路，尤其通过调控YAP/TAZ蛋白的表达、磷酸化水平及影响其核定位从而促进疾病的发生。首先，病毒侵染后可通过其编码蛋白直接影响YAP/TAZ的表达，促进肿瘤发生。如HBV编码的HBx蛋白与CREB结合激活YAP启动子促进YAP表达。除了影响启动子活力外，HBx蛋白也能通过下调miRNA-375促进YAP表达 [<xref ref-type="bibr" rid="hanspub.39866-ref22">22</xref>]，preS2蛋白则通过抑制miRNA-338-3p促进TAZ蛋白表达，从而促进肝癌细胞的增殖及迁移 [<xref ref-type="bibr" rid="hanspub.39866-ref23">23</xref>]。此外，HBx互作蛋白HBXIP还通过激活转录因子c-Myb上调肝癌细胞中YAP的表达，促进肝癌发生 [<xref ref-type="bibr" rid="hanspub.39866-ref24">24</xref>]。EBV病毒感染通过其编码的LMP1蛋白促进TAZ表达，从而调控鼻咽癌发生 [<xref ref-type="bibr" rid="hanspub.39866-ref25">25</xref>]。然而，在ZIKV感染模型中沉默YAP/TAZ表达，则可抑制ZIKV复制、增值，最终影响疾病发生 [<xref ref-type="bibr" rid="hanspub.39866-ref26">26</xref>]。其次，病毒也能通过影响YAP磷酸化水平从而调控疾病发生。如HPV编码E6蛋白可下调YAP<sup>S397</sup>位磷酸化水平，从而促进宫颈癌发生 [<xref ref-type="bibr" rid="hanspub.39866-ref27">27</xref>]。研究表明YAP/TAZ最终发挥功能一般通过入核后激活下游靶基因表达，从而促进肿瘤发生。如HPV编码的E6蛋白与PDZ结构蛋白互作后调控YAP的核定位，从而影响宫颈癌发生 [<xref ref-type="bibr" rid="hanspub.39866-ref28">28</xref>]。这样的调控机制同样发生在EBV病毒上。EBV病毒编码的LMP1蛋白通过与凝溶胶蛋白相互作用抑制LATS1/2磷酸化，从而稳定了YAP/TAZ并促进其核转移，最终诱发鼻咽癌 [<xref ref-type="bibr" rid="hanspub.39866-ref25">25</xref>]。最后，病毒也通过影响Hippo通路上游激酶活性进而影响YAP/TAZ活力，从而促进肿瘤疾病发生。例如KSHV编码的vGPCR蛋白通过抑制LATS1/2激酶活性，从而激活YAP/TAZ，最终促进肿瘤细胞增殖和转化 [<xref ref-type="bibr" rid="hanspub.39866-ref29">29</xref>]。</p><p>综上，常见人类病毒主要通过其编码的病毒蛋白调控YAP/TAZ蛋白表达、上游激酶及自身磷酸化水平、以及YAP/TAZ蛋白的核定位等促进肿瘤等疾病的发生。</p></sec><sec id="s9"><title>5. YAP/TAZ蛋白与免疫</title><p>天然免疫系统通过区别自身和非自身，构成对抗病毒侵染的第一道防线。研究表明Hippo通路中YAP蛋白负调控天然抗病毒免疫且YAP对天然免疫的调控独立于上游激酶。天然免疫细胞可通过细胞内受体识别病毒，如RIG-I，cGAS等。病毒侵染后，胞内受体RIG-I和cGAS可激活IKKε及TBK1激酶，进而招募IRF3，促进IRF3磷酸化、二聚化及入核，从而诱导其效应基因IFNs表达。而YAP通过抑制IRF3二聚化及其核定位负调控抗病毒天然免疫。研究表明，当YAP被敲除后，天然免疫增强，病毒载量下降 [<xref ref-type="bibr" rid="hanspub.39866-ref30">30</xref>]。此外，病毒侵染宿主后，宿主也能通过IKKε影响YAP磷酸化，下调YAP表达，进而增强天然抗病毒免疫反应 [<xref ref-type="bibr" rid="hanspub.39866-ref31">31</xref>]。研究表明，YAP/TAZ也能与TBK1直接作用，抑制TBK1第63位赖氨酸泛素化，消除病毒诱导TBK1激活，从而抑制天然免疫 [<xref ref-type="bibr" rid="hanspub.39866-ref2">2</xref>]。</p><p>此外，YAP蛋白在抗肿瘤免疫中也发挥重要作用。YAP能直接调控PD-L1转录，使得PD-L1与免疫识别受体PD-1相互作用，避免免疫监视。YAP也能通过促进肿瘤分泌因子的表达，进而促进免疫抑制细胞的招募，抑制免疫反应对肿瘤细胞的调控；此外，YAP通过激活CAFs促进肿瘤免疫抑制。研究表明CAFs通过释放大量的免疫抑制细胞因子，促进免疫逃避。综上，YAP负调控天然抗病毒免疫及抗肿瘤免疫 [<xref ref-type="bibr" rid="hanspub.39866-ref32">32</xref>]。</p></sec><sec id="s10"><title>6. 展望</title><p>文章概括了Hippo信号通路YAP/TAZ蛋白在控制细胞增殖，肿瘤发生以及病毒诱导疾病、影响免疫反应等方面的作用。文章旨在阐明病毒诱导肿瘤与Hippo通路YAP/TAZ蛋白之间的联系，推广Hippo通路YAP/TAZ参与调控的肿瘤发病机理，从而为寻找治疗疾病靶点提供一些参考，以便研发相关药物，加快临床治疗进程。</p><p>虽然有许多关键问题未被阐明，但我们感兴趣之处在于是否可以通过人为干预Hippo信号通路从而治疗由病毒感染引起的疾病。用药物调控Hippo信号通路组分可能会为预防病毒性疾病提供一些线索。例如VP和VGLL4等药物能够抑制YAP和TEAD之间相互作用。研究表明VP药物对卵巢癌细胞增值呈现时间和剂量抑制作用，并能抑制癌细胞的迁移和侵袭。而VGLL4与YAP直接竞争结合TEAD从而抑制肺癌细胞增值 [<xref ref-type="bibr" rid="hanspub.39866-ref33">33</xref>] [<xref ref-type="bibr" rid="hanspub.39866-ref34">34</xref>]。因此，我们可以着眼于研发更多靶向YAP/TAZ的药物，通过抑制YAP/TAZ表达、磷酸化修饰，抑制YAP/TAZ与其上下游蛋白的互作，从而阻碍病毒编码蛋白对YAP/TAZ调控，从而实现抑制人类病毒感染、传播及致病的作用，对预防病毒侵染具有重要生理意义。</p></sec><sec id="s11"><title>基金项目</title><p>国家自然科学基金项目(31970173)；国家级大学生创新创业训练计划(202010345019)。</p></sec><sec id="s12"><title>文章引用</title><p>邹 丰,苟洪伟,黄金华,李晨辉,赵铁军. YAP/TAZ蛋白调控病毒侵染与免疫的研究进展Research Progress of YAP/TAZ Protein Regulating Virus Infection and Immunity[J]. 生物医学, 2021, 11(01): 8-13. https://doi.org/10.12677/HJBM.2021.111002</p></sec><sec id="s13"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.39866-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, B., Li, L., Lei, Q., et al. (2010) The Hippo-YAP Pathway in Organ Size Control and Tumorigenesis: An Updated Version. Genes &amp; Development, 24, 862-874. &lt;br&gt;https://doi.org/10.1101/gad.1909210</mixed-citation></ref><ref id="hanspub.39866-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, Q., Meng, F., Chen, S., et al. (2017) Hippo Signalling Governs Cytosolic Nucleic Acid Sensing through YAP/TAZ-Mediated TBK1 Blockade. Nature Cell Biology, 19, 362-374. &lt;br&gt;https://doi.org/10.1038/ncb3496</mixed-citation></ref><ref id="hanspub.39866-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Hong, L., Li, X., Zhou, D., et al. (2018) Role of Hippo Signaling in Regulating Immunity. Cellular &amp; Molecular Immunology, 15, 1003-1009. &lt;br&gt;https://doi.org/10.1038/s41423-018-0007-1</mixed-citation></ref><ref id="hanspub.39866-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Taha, Z., van Rensburg, H.J.J. and Yang, X. (2018) The Hippo Pathway: Immunity and Cancer. Cancers (Basel), 10, 94. &lt;br&gt;https://doi.org/10.3390/cancers10040094</mixed-citation></ref><ref id="hanspub.39866-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Piccolo, S., Dupont, S. and Cordenonsi, M. (2014) The Biology of YAP/TAZ: Hippo Signaling and Beyond. Physiological Reviews, 94, 1287-1312. &lt;br&gt;https://doi.org/10.1152/physrev.00005.2014</mixed-citation></ref><ref id="hanspub.39866-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, B., Wei, X., Li, W., et al. (2007) Inactivation of YAP Oncoprotein by the Hippo Pathway Is Involved in Cell Contact Inhibition and Tissue Growth Control. Genes &amp; Development, 21, 2747-2761.  
&lt;br&gt;https://doi.org/10.1101/gad.1602907</mixed-citation></ref><ref id="hanspub.39866-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Boggiano, J.C., Vanderzalm, P.J. and Fehon, R.G. (2011) Tao-1 Phosphorylates Hippo/MST Kinases to Regulate the Hippo-Salvador-Warts Tumor Suppressor Pathway. Developmental Cell, 21, 888-895.  
&lt;br&gt;https://doi.org/10.1016/j.devcel.2011.08.028</mixed-citation></ref><ref id="hanspub.39866-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Oka, T., Mazack, V. and Sudol, M. (2008) Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-Associated Protein (YAP). Journal of Biological Chemistry, 283, 27534-27546.  
&lt;br&gt;https://doi.org/10.1074/jbc.M804380200</mixed-citation></ref><ref id="hanspub.39866-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Ni, L., Zheng, Y., Hara, M., Pan, D. and Luo, X. (2015) Structural Basis for Mob1-Dependent Activation of the Core Mst-Lats Kinase Cascade in Hippo Signaling. Genes &amp; Development, 29, 1416-1431.  
&lt;br&gt;https://doi.org/10.1101/gad.264929.115</mixed-citation></ref><ref id="hanspub.39866-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Yin, F., Yu, J., Zheng, Y., et al. (2013) Spatial Organization of Hippo Signaling at the Plasma Membrane Mediated by the Tumor Suppressor Merlin/NF2. Cell, 154, 1342-1355. &lt;br&gt;https://doi.org/10.1016/j.cell.2013.08.025</mixed-citation></ref><ref id="hanspub.39866-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yu, F.X., Zhao, B., Panupinthu, N., et al. (2012) Regulation of the Hippo-YAP Pathway by G-Protein-Coupled Receptor Signaling. Cell, 150, 780-791. &lt;br&gt;https://doi.org/10.1016/j.cell.2012.06.037</mixed-citation></ref><ref id="hanspub.39866-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Yu, F.X., Zhang, Y., Park, H.W., et al. (2013) Protein Kinase A Activates the Hippo Pathway to Modulate Cell Proliferation and Differentiation. Genes &amp; Development, 27, 1223-1232. &lt;br&gt;https://doi.org/10.1101/gad.219402.113</mixed-citation></ref><ref id="hanspub.39866-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Meng, Z., Moroishi, T., Mottier-Pavie, V., et al. (2015) MAP4K Family Kinases Act in Parallel to MST1/2 to Activate LATS1/2 in the Hippo Pathway. Nature Communications, 6, Article No. 8357. &lt;br&gt;https://doi.org/10.1038/ncomms9357</mixed-citation></ref><ref id="hanspub.39866-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, B., Li, L., Tumaneng, K., Wang, C.Y. and Guan, K.L. (2010) A Coordinated Phosphorylation by Lats and CK1 Regulates YAP Stability through SCFβ-TRCP. Genes &amp; Development, 24, 72-85. &lt;br&gt;https://doi.org/10.1101/gad.1843810</mixed-citation></ref><ref id="hanspub.39866-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Zhao, B., Ye, X., Yu, J., et al. (2008) TEAD Mediates YAP-Dependent Gene Induction and Growth Control. Genes &amp; Development, 22, 1962-1971. &lt;br&gt;https://doi.org/10.1101/gad.1664408</mixed-citation></ref><ref id="hanspub.39866-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Moroishi, T., Hansen, C.G. and Guan, K.L. (2015) The Emerging Roles of YAP and TAZ in Cancer. Nature Reviews Cancer, 15, 73-79. &lt;br&gt;https://doi.org/10.1038/nrc3876</mixed-citation></ref><ref id="hanspub.39866-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Kang, W., Cheng, A.S., Yu, J., et al. (2016) Emerging Role of Hippo Pathway in Gastric and Other Gastrointestinal Cancers. World Journal of Gastroenterology, 22, 1279-1288. &lt;br&gt;https://doi.org/10.3748/wjg.v22.i3.1279</mixed-citation></ref><ref id="hanspub.39866-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, L., Yang, S., Chen, X., et al. (2015) The Hippo Pathway Effector YAP Regulates Motility, Invasion, and Castration-Resistant Growth of Prostate Cancer Cells. Molecular and Cellular Biology, 35, 1350-1362.  
&lt;br&gt;https://doi.org/10.1128/MCB.00102-15</mixed-citation></ref><ref id="hanspub.39866-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Harvey, K.F., Zhang, X. and Thomas, D.M. (2013) The Hippo Pathway and Human Cancer. Nature Reviews Cancer, 13, 246-257. &lt;br&gt;https://doi.org/10.1038/nrc3458</mixed-citation></ref><ref id="hanspub.39866-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Xia, Y., Chang, T., Wang, Y., et al. (2014) YAP Promotes Ovarian Cancer Cell Tumorigenesis and Is Indicative of a Poor Prognosis for Ovarian Cancer Patients. PLoS One, 9, e91770. &lt;br&gt;https://doi.org/10.1371/journal.pone.0091770</mixed-citation></ref><ref id="hanspub.39866-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Gomez, M., Gomez, V. and Hergovich, A. (2014) The Hippo Pathway in Disease and Therapy: Cancer and Beyond. Clinical and Translational Medicine, 3, 22. &lt;br&gt;https://doi.org/10.1186/2001-1326-3-22</mixed-citation></ref><ref id="hanspub.39866-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, T., Zhang, J., You, X., et al. (2012) Hepatitis B Virus X Protein Modulates Oncogene Yes-Associated Protein by CREB to Promote Growth of Hepatoma Cells. Hepatology, 56, 2051-2059. &lt;br&gt;https://doi.org/10.1002/hep.25899</mixed-citation></ref><ref id="hanspub.39866-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Liu, P., Zhang, H., Liang, X., et al. (2015) HBV preS2 Promotes the Expression of TAZ via miRNA-338-3p to Enhance the Tumorigenesis of Hepatocellular Carcinoma. Oncotarget, 6, 29048-29059.  
&lt;br&gt;https://doi.org/10.18632/oncotarget.4804</mixed-citation></ref><ref id="hanspub.39866-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Wang, Y., Fang, R., Cui, M., et al. (2017) The Oncoprotein HBXIP Up-Regulates YAP through Activation of Transcription Factor c-Myb to Promote Growth of Liver Cancer. Cancer Letters, 385, 234-242.  
&lt;br&gt;https://doi.org/10.1016/j.canlet.2016.10.018</mixed-citation></ref><ref id="hanspub.39866-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">He, J., Tang, F., Liu, L., et al. (2017) Positive Regulation of TAZ Expression by EBV-LMP1 Contributes to Cell Proliferation and Epithelial-Mesenchymal Transition in Nasopharyngeal Carcinoma. Oncotarget, 8, 52333-52344.  
&lt;br&gt;https://doi.org/10.18632/oncotarget.13775</mixed-citation></ref><ref id="hanspub.39866-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Garcia, G., Paul, S., Beshara, S., et al. (2020) Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication and in the Pathogenesis of Neuroinflammation. The American Journal of Pathology, 190, 844-861.  
&lt;br&gt;https://doi.org/10.1016/j.ajpath.2019.12.005</mixed-citation></ref><ref id="hanspub.39866-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">He, C., Mao, D., Hua, G., et al. (2015) The Hippo/YAP Pathway Interacts with EGFR Signaling and HPV Oncoproteins to Regulate Cervical Cancer Progression. EMBO Molecular Medicine, 7, 1426-1449.  
&lt;br&gt;https://doi.org/10.15252/emmm.201404976</mixed-citation></ref><ref id="hanspub.39866-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Strickland, S.W., Brimer, N., Lyons, C., et al. (2018) Human Papillomavirus E6 Interaction with Cellular PDZ Domain Proteins Modulates YAP Nuclear Localization. Virology, 516, 127-138.  
&lt;br&gt;https://doi.org/10.1016/j.virol.2018.01.003</mixed-citation></ref><ref id="hanspub.39866-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Liu, G., Yu, F.X., Kim, Y.C., et al. (2015) Kaposi Sarcoma-Associated Herpesvirus Promotes Tumorigenesis by Modulating the Hippo Pathway. Oncogene, 34, 3536-3546. &lt;br&gt;https://doi.org/10.1038/onc.2014.281</mixed-citation></ref><ref id="hanspub.39866-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Wang, S., Xie, F., Chu, F., et al. (2017) YAP Antagonizes Innate Antiviral Immunity and Is Targeted for Lysosomal Degradation through IKKɛ-Mediated Phosphorylation. Nature Immunology, 18, 733-743.  
&lt;br&gt;https://doi.org/10.1038/ni.3744</mixed-citation></ref><ref id="hanspub.39866-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Kim, N., Park, Y.Y., Joo, C.H. and Kim, H.S. (2018) Relief of YAP-Mediated Inhibition by IKKɛ Promotes Innate Antiviral Immunity. Cellular &amp; Molecular Immunology, 15, 642-644. &lt;br&gt;https://doi.org/10.1038/cmi.2017.97</mixed-citation></ref><ref id="hanspub.39866-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">White, S.M., Murakami, S. and Yi, C. (2019) The Complex Entanglement of Hippo-Yap/Taz Signaling in Tumor Immunity. Oncogene, 38, 2899-2909. &lt;br&gt;https://doi.org/10.1038/s41388-018-0649-6</mixed-citation></ref><ref id="hanspub.39866-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Feng, J., Gou, J., Jia, J., Yi, T., Cui, T. and Li, Z. (2016) Verteporfin, a Suppressor of YAP-TEAD Complex, Presents Promising Antitumor Properties on Ovarian Cancer. OncoTargets and Therapy, 9, 5371-5381.  
&lt;br&gt;https://doi.org/10.2147/OTT.S109979</mixed-citation></ref><ref id="hanspub.39866-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Zhang, W., Gao, Y., Li, P., et al. (2014) VGLL4 Functions as a New Tumor Suppressor in Lung Cancer by Negatively Regulating the YAP-TEAD Transcriptional Complex. Cell Research, 24, 331-343. &lt;br&gt;https://doi.org/10.1038/cr.2014.10</mixed-citation></ref></ref-list></back></article>